Welcome to Nordic Life Science Days 2014!Invest – Partner – Network7-9 September 2014Explore cutting-edge Nordic science and technologies. This year together with European Cancer Cluster Partnering.

Premium Sponsors Plat inum Sponsors

NLSDays co-hosted by

ECCP co-hosted by

Produced by

Welcome!

ECCP - Cancer Immunotherapies9 Sept, 09:00 - 10:30 Room C1/C2 - Level 2

Novel opportunities via disruptive innovation and Innovation ecosystems in Immuno-Oncology.

Speakers: Dr. Lubor Gaal, Head of Europe, Strategic Transactions Group, Bristol-Myers Squibb - Dr. Loic Vincent, Oncology division, Oncology Business Oppor-tunity, Sanofi - Dr. Bertil Jonsson, MD, Vice-Chair, CHMP Efficacy Working Party - Human Medicines & Swedish Medical Products Agency - Ms. Sybille Lenz, CEO Alligator Bioscience, Medicon Valley, Sweden / Denmark - Mr. Øyvind Arnesen, CEO Ultimovacs AS, Oslo Cancer Cluster, Norway - Pr. Jean-Jacques Fournié, Director Cancer Research Center of Toulouse, France - Mr. Erwan Corcuff, CEO Axenis, Cancer Campus / Medicen, France - Mr. Dominique Demonté, Director of the Biopark Charleroi Brussels South, Université Libre de Bruxelles, BioWin, Wallonia, BelgiumModerator: Dr. Johan Christenson, Partner, HealthCap

Recent Trends in Neuroscience 9 Sept, 09:00 - 10:30Room C3 - Level 2

New trends and developments helping to translate research in neuroscience into novel therapies for such disorders.

Speakers: Dr. Bengt Winblad, Professor, Karolinska Institute - Dr. Gunilla Oss-wald, CEO, BioArctic Neuroscience AB - Dr Eric Karran, Director of Research, Alzheimer›s Research UK - Mr. Frank Swenson, Director Diagnostics, PharmaTX Precision Medicine, PfizerModerator: Mr. Leif Rune Skymoen, CEO, Nansen Neuroscience Network

Nordic Landscape and Nordic Stars Awdard9 Sept, 14:00 - 15:30Room C1/C2/C3 - Level 2

EY presents the Nordic Life Sciences Sector Report and the Winners of the Nordic Stars Awards are announced.

Speakers: Mr. Jan-Olof Jacke, VP Finance, Global Products & Portfolio Strat-egy and R&D at AstraZeneca and President AstraZeneca AB - Mr. Kim Sandell, Director Business and Supply, Pfizer - Mr. Jesper Eriksson, Operational Excel-lence, Black belt 6, Pfizer, Ms. Ylva Berg, President and CEO at Business Sweden – The Swedish Trade & Invest Council - Mr. Frederic Lacuppinad, Man-aging General and Partner, DirectureModerator: Ms. Tanja Dowe, Managing Partner, Innomedica Ltd

Opening session 8 Sept, 09:00 - 10:30 Room C1/C2/C3 - Level 2

The Nordic Region, a region at the forefront of global development in Life Sciences & Healthcare

Welcome address: Dr. Jonas Ekstrand, CEO, SwedenBIOSpeakers: Dr. Jan M Lundberg, Executive Vice President, Science and Tech-nology, and President, Lilly - Dr. Lene Lange, Director of Research, Professor in Biotechnology and Campus Director for Aalborg University Copenhagen - Dr. Charlotte Brogren, General Director, Vinnova - Dr. Ulrika Sehlstedt, Principal, Healthcare, Arthur D. LittleModerator: Mr. Jan Wifstrand, CEO & funder, Rapidus

Investors pitching8 Sept, 11:00 - 12:30 Room C1/C2/C3 - Level 2

Investors Pitching in a Row – Who We are and What We Want!

Speakers: Mr. David Phillips, VP & Partner, SR One GSK - Mr. Viktor Drvota, SEB Venture Capital - Mr. Per Aniansson, Investment Director, Fouriertransform - Mr. Claes Post, Investment Manager, Almi Invest - Dr Marten Steen, Partner, HealthCap - Mr. Carl-Johan Spak, Executive VP, Development & Technology, Recipharm Venture Fund - Mr. Eric de la Fortelle, Venture Partner, Seventure Partners - Dr. Bobby G. Soni, Investment Director, Novo Seeds - Mr. Claus Asbjørn Andersson, Partner, Sunstone Capital - Mr. Jasper Bos, Director, Merck Serono Ventures - Mr. Christopher de Souza, Director, Broadview Ventures - Ms. Hedvig Andersen, Investment Manager, IndustrifondenModerator: Dr. Nina Rawal, Investment Manager Life Science, Industrifonden

Chronic Diseases: Cardiovascular and Autoimmune Diseases 8 Sept, 14:00 - 15:30 Room C3 - Level 2

The Future of Therapies in Cardiovascular Disease and Driving Innovation in Inflammatory Autoimmune Diseases.

Speakers: Ms. Elisabeth Björk, VP CVMD Global Medicines Development and Site Lead AZ Mölndal, R&D, AstraZeneca - Mr. Jan Fjellström, partner at ScientificMed - Ms. Carina Schmith CEO, Athera Biotechnologies - Dr. Anand Gautam, Director, Innovation Sourcing , Novo Nordisk - Dr. Ola Winqvist, Professor, Karolinska University Hospital & Immune Therapy Holding - Dr. Jean de Serres, CEO, Héma-Québec

Moderator: Dr. Anders Ekblom, MD, Board member, SwedenBIO

Highligts at Nordic Life Science Days

Program

Gold Sponsors

07:30 Exhibition Open Networking Hall - Level 407:30 Welcome Breakfast Networking Hall - Level 409:00 Welcome & Opening Session, The

Nordic Region, a region at the fo-refront of global development in Life Sciences & Healthcare

Room C1/C2/C3 - Level 2

10:30 Break Networking Hall - Level 411:00 International Investors Session Room C1/C2/C3 - Level 2

Monday 8 September

Sunday 7 September19:00 - 20:30 Welcome Reception Networking Hall - Level 4

12:30 Lunch Networking Hall - Level 413:30 Face-to-Face Meetings Business Forum - Level 313:30 Company & Pitching Podium

PresentationsRoom 26 - Level 2

14:00 Pharma & Company Presenta-tions

Room 27 - Level 2

14:00 The New Innovation Ecosystem Room C1/C2 - Level 214:00 Chronic Diseases: Cardiovascu-

lar and Autoimmune diseasesRoom C3 - Level 2

15:30 Break Networking Hall - Level 416:00 ECCP - Early Stage Oncology

OpportunitiesRoom C1/C2 - Level 2

16:00 Nordic-Swiss Innovation Partnerships

Room C3 - Level 2

19:00 Official Networking Reception Stockholm City Hall

THE EUROPEAN UNIONThe European Regional

Development Fund

07:30 Exhibition Open Networking Hall - Level 407:30 Welcome Breakfast Networking Hall - Level 408:00 Face-to-Face Meetings Business Forum - Level 308:30 Company and Pitching Podium

PresentationsRoom 26 - Level 2

09:00 Pharma and Company Presen-tations

Room 27 - Level 2

09:00 ECCP - Cancer Immunothera-pies

Room C1/C2 - Level 2

09:00 Medical Needs and Recent Trends in Neuroscience

Room C3 - Level 2

10:30 Break Networking Hall - Level 4

Tuesday 9 September 11:00 ECCP - Biomarkers, Biobanks

and Big Data in OncologyRoom C1/C2 - Level 2

11:00 Redefining Early Stage Invest-ments

Room C3 - Level 2

12:30 Lunch Networking Hall - Level 4

14:00 Nordic Landscape & Nordic Stars Awards

Room C1/C2/C3 - Level 2

15:30 Break Networking Hall - Level 4

16:00 Closing Plenary - What needs to be improved in the Innova-tion Ecosystem and how will I contribute ?

Room C1/C2/C3 - Level 2

17:00 Closing Reception Networking Hall - Level 4

Trondheim

Gothenburg

Lund/Malmö

StockholmUppsala

Oslo

Umeå

Aalborg

Aarhus

Odense

Helsinki

Turku

Copenhagen

Medicon Valley

Reykjavik

Tampere

Koupio

Oulo

The Hottest Life Science Clusters in the Nordic region

■ Almost 40,000 people work in the Swedish life science sector.

■ Sweden invests most money per capita in Europe in life science research.

■ AstraZeneca, Medivir, Orexo, Sobi, Elekta and Sectra are examples of companies that were founded and developed in Sweden.

■ In addition to these, there are around 800 life science companies in the country.

■ With 45,000 employees in over 300 companies, Denmark is an international player to be reckoned with.

■ In 2013 Denmark ranked number one in Europe and second in the world after the US in The Worldview Report and Bio-Innovation Scorecard.

■ Companies include Novo Nordisk, Lundbeck, Leo Pharma, Coloplast and Novozymes.

■ Iceland has a unique register of medical and genetic data on large sections of the population.

■ Research projects usually achieve 70–90% voluntary participation in Iceland.

■ Companies include Decode Genetics, a global leader in analysing and understanding the human genome for the development of therapies.

■ The Oslo Cancer Cluster has led to Norway becoming established on the international stage.

■ The cluster brings together 70 members from academic institutions and industry in Norway and Northern Europe and covers the entire value chain for the development of new cancer therapies. Companies such as Algeta (purchased by Bayer) and Vaccibody were created from this cluster.

■ In addition to the focus on cancer, Norway has a thriving medtech industry with over 200 companies.

■ Finland has around 200 companies collaborating closely with its 15 universities that are active in the field of life science.

■ Orion Pharma, Biotie Therapies and Oncos Therapeutics are some of the country’s companies in this area.

SwedenDenmark

Iceland

Norway Finland

PMS 268

Gold Sponsors

Companies RegisteredCompany Name 3B Pharmaceuticals Gmbh 3D-Pharmxchange 3P Biopharmaceuticals A+ Science Ab Aalborg University Abbvie Accelera Srl Accelerace Acib - Across Innovation Borders Acreo Swedish Ict Adlego Biomedical Ab Admescope Ait Austrian Institute Of Technology

Gmbh Akademiska Sjukhuset / Uppsala

University Hospital Alligator Bioscience Ab Almi Invest Alrise Biosystems Gmbh Alzecure Alzheimer’S Research Uk American Embassy Amgen (Europe) Gmbh Amgen Inc. Analytical Biochemical Laboratory Analytical Services Dr. Ralph Nuss-

baum Apim Therapeutics As Apl Apotekarsocieteten Aprea Ab Arandi Development Arthur D. Little Asahi Kasei Bioprocess Ascenion Gmbh Aseptic Technologies Assign Group Association Of German Biotechno-

logy Companies - Vbu Astrazeneca Athera Biotechnologies Ab Atlantic Bone Screen Aurora Partners K.K. Avalon Health Economics Avestin, Inc Axcentua Pharmaceuticals Ab Axenis Axiogenesis Ag Bayer Pharma Ag Beactica Bergen Teknologioverføing As Berlin Partner For Business And

Technology Gmbh Bia Separations Gesmbh Bio-Works Technologies Ab Biocentury Publications Inc. Bioconnection Bv Biognos Ab Biomeva Gmbh Bioneer A/S Biopeople Biotech Umeå Biotechgate Ag Biotechsubsidy Biotem Bioturku Biovian Ltd Biovica International Biowin Biq Pharma Ab Birk Venture Blueprint Genetics Boehringer Ingelheim Bone Index Finland Ltd. Boyds Brann Ab Bristol-Myers Squibb British Embassy - Uk Trade And

Investment Broadview Ventures, Inc Business Region Göteborg Ab Business Sweden

C.Ris Pharma Calixar Sas Cambrex Corporation Camurus Ab Cancer Campus Carbogen Amcis Ag Cascination Ag Cea-Leti-Health Ceffort Ab Cellseed Inc. Chelatec Chemconnection China Sweden Life Science Associa-

tion Chu De Toulouse : Toulouse Hospi-

tals Citoxlab Scantox Clinical Research Services Turku

Crst Clinstorage Ab Clintrials Skåne Ab Cmc Biologics Cobra Biologics Conimar Copenhagen Capacity Cormorant Pharmaceuticals Cote Orphan Consulting Covance Cr Competence Ab Cr Development Crown Cro Oy Ctc Clinical Trial Consultants Ab Current Partnering Cytoo Damian Pharma Danish Health And Medicines

Autho rity Danpet Debiopharm International S.A. Delphi Genetics Delsitech Ltd Diamyd Medical Dilaforette Ab Discoverx Disruptive Materials Dottikon Exclusive Synthesis Ag Drugdesigntech Sa Dupont Sverige Ab - Chemoswed Dybly Ag Eban Ebs Technologies Gmbh Ecron Acunova Eli Lilly And Company Embassy Of Canada Endoverend Ab Episentec Epsitem Essen Bioscience Ltd Eurasante Euro Diagnostica European Biopharmaceutical Enter-

prises European Biotechnology Network Evaluatepharma Expres2Ion Biotechnologies Exscale Biospecimen Solutions Ab F Hoffmann La Roche Faes Farma, S. A. Finnish Bioindustries Flanders Investment & Trade Flandersbio Flex Databases Europe Sa Fluofarma Foi - Swedish Defence Research

Agency Foundation Toulouse Cancer Health

(Innabiosanté) Fouriertransform Freemind Group Fundedbyme Gaea Gamamabs Pharma Gct

Ge Healthcare Gelscom Sas Genibet Biopharmaceuticals Genmab A/S Genohm George James Ltd Gill Jennings & Every Gill Jennings & Every Llp Glenmark Pharmaceuticals S.A Global Care Initiative Globaldata Grace Greater Geneva Berne Area (Ggba) Grespo Ab Grünenthal Gu-Holding Hadean Ventures Halix B.V. Hays Ag Healthcap Hellström Helsinki Business Hub (Greater

Helsinki Promotion Ltd.) Helsinki Innovation Services Héma-Québec Herantis Pharma Plc Horn Publishing Hospira One 2 One Hugin&Munin Nordic Hunan Kangbo Pharmaceuticals Hungarotrial Zrt. Huntingdon Research Centre Icelltis Iddi Ideon Ab Ido Illingworth Research Limited Imaging Resource Ab Immunehealth Index Pharmaceuticals Industrifonden Innomedica Innovation Norway Innovationspatent Sverige AbInnovator Skåne Inova Software Instinctif Partners Institut Pasteur Insymbiosis Integrated Dna TechnologiesIntegrative Research Laboratories

Sweden Ab International Society For Stem Cell

Research Interpretomics India Pvt. Ltd., Inven2 Inventiva Invest In Skåne Invest In Toulouse Invest-Quebec Invivo Biotech Services Gmbh Ipsen Pharma Irw Consulting Ab Janssen Nordics Johnson & Johnson Innovation

Centre Johnson And Johnson Jpt Peptide Technologies Gmbh Kancera Ab Karo Bio Ab Karolinska Institute Karolinska Institutet Science Park Karolinska Institutet/Nerve Kaye Advanced Sensors Kdev Oncology Kemikan Key Organics Ltd Kinesis Pharma B.V. Klifo A/S Kubator Therapeutics Ab Labjoy Ab Leads To Development Lee’S Pharmaceutical Limited

Lendau Capital Ab Lifandis As Life Science Foresight Institute Life Science Nation Life Science Sweden Liftstream Ltd Link Medical Research Lipopharma Therapeutics Sl Lithuanian Embassy Lonza Lu Innovation System Lund Life Science Incubator Lund University Lund University Diabetes Center Lytix Biopharma Mc Professional Ltd Md Anderson Cancer Center Medeon Medeon Science Park Medfiles Ltd Medicon Village Medicortex Finland Oy Medicyte Gmbh Medipan Gmbh Medivir Medscinet Ab Merieux Developpement Mevia Milmedtek Ab Ministère Des Affaires Étrangères Molecules Of Man Ab Monitus Research Ltd London Monocl Moretime Business Partner Ab Ms Ventures Msd Mvm Life Science Partner Myelo Therapeutics Gmbh Nanolive Sa Nanologica Ab Nansen Neuroscience Network Nasdaq Omx Nda Group Ab Nerve Ab Neurotar Ltd Newtech Ab Nextera As Nextpharma Nixon Peabody Llp Nmi Reutlingen Noorik Biopharmaceuticals Ag Nordicbiocube Norgenta North German Life

Science Agency Gmbh Norma Norwegian Cancer Society Norwegian Medicines Agency Norwegian University Of Science

And Technology Novandi Chemistry Ab Novartis Sverige Ab Novo A/S Novo Nordisk Novozymes Biopharma Ntnu Technology Transfer Ny Consulting Ocr Oncodna Oncomedics Oncorena Ab /Puls Oncos Therapeutics Ltd. Ontarget Chemistry Onyx Scientific Opsona Therapeutics Oslo Cancer Cluster Ossdsign Ab Oy Medfiles Ltd P.U.L.S. Ab Parexel International Partner Patheon Pcg Solutions Pci Biotech Holding Asa

Pelago Bioscience Ab Pennsylvania Center For Direct

Investment Pfizer Pfizer Centre Source Pfizer Health Ab Pfizer Pgrd Pharm-Analyt Lab. Gmbh Pharma Consulting Group Ab Pharmacontrol Pharmanest Pharmatelevision Pharmatory Ltd Pharmaventures Photo Dynamic Therapy Llc Physiostim Piramal Healthcare Care Piramal Pharma Inc. Pledpharma Ab Potter Clarkson Llp Pra Health Sciences Pre Diagnostics As Preclin Biosystems Ag Projektsupport S-O Ab Promega Biotech Ab Protagen Protein Services Gmbh Psilox Ab Psoriasisförbundet Px’Therapeutics Q&Q Labs Qps Quay Pharma Quintiles Rapidus Reagensia Ab Recipharm Recipharm Pharmaceutical Develop-

ment Recipharm Venture Fund Red Glead Discovery Redoxis Ab Region Skåne Richard Christison - Freelance Pro-

tein Expression Scientist Richter-Helm Biotec Ridgeview Diagnostics Ab Rtc, Research Toxicology Centre Spa Sahlgrenska Science Park Salipro Biotech Ab Saniona Sanofi Sanofi Oncology Sanofi R&D Sanofi-Aventis Deutschland Gmbh Saromics Biostructures Ab Scanbalt Scandinavian Development Services Scientificmed Scottish Development International Seb Venture Capital Selvita S.A. Seventure Partners Sherbrooke Innopole Sigrid Therapeutics Sirion Biotech Gmbh Sms-Oncology Sofus Regulatory Affairs Ab Solve Research And Consultancy Ab Solvo Biotechnology Sompharmaceuticals Soventec Gmbh Sp Technical Research Institute Of

Sweden Spanish Embassy Spiber Technologies Ab Sprint Bioscience Sr One State Secretariat For Education,

Research And Innovation Stemgent Asterand Sting Stockholm Business Region Develop-

ment Ab

Superecg Swedbank Swedenbio Swedish Academy Of Pharmaceutical

Sciences (Läkemedels akademin) Swedish Medtech Swedish Network For Innovation

And Technology Transfer Support Swedish Pharmaceutical Society Swiss Biotech Association Sygnature Discovery Ltd Symbiosis Pharmaceutical Services

Ltd Syncrosome Synthon Biopharmaceuticals Bv Targovax As Technology Transfer Office Tekes Tfs The Canadian Embassy The Swedish Association Of The

Pharmaceutical Industr, Lif The Swedish Medical Products

Agency The Wellcome Trust Theradex Europe Therapure Biopharma Thor Life Science Consulting Ab Toleranzia Ab Toxicology Knowledge Team Swe-

den Ab Truly Translational Sweden Ab Turku Science Park Ltd Uk Trade And Investment Ultimovacs As Umeå Biotech Incubator Ab Uminova Invest Unither Pharmaceuticals University Of Oslo And Oslo Univer-

sity Hospitals University Of Southern Denmark Uppsala Bio Uppsala Innovation Centre Uppsala Innovation Centre Ab Uppsala University Uppsala University Innovation Vaccibody As Valea Ab Valirx Plc Vasco Advisers Vectalys Verdens Gang, Vg Vicore Pharma Vinge Law Firm Vinnova Vironova Biosafety Viva Biotech Vtt Technical Research Centre Of

Finland Wallonia (Belgium) Trade & Invest-

ment Office Wallonia.Be Export-Invest (Awex) Wil Research Wombat Capital Sas World Courier (Sweden) Ab Xiber Science Gmbh Xizang Haisco Pharma Group Co.,

Ltd Xspray Microparticles Ab Xvivo Perfusion Ab Yo Proteins Ab Zhangguang 101 Holding Group Zoetis

Book your one-on-one meeting at

nlsdays.com/partnering

Partnering at NLSDays and ECCP 2014 is powered by:

Connecting Products, Services & Capital

LIFE SCIENCENATION

Si lver Sponsors

List contains companies registered 25 august 2014

Stockholm Waterfront

Si lver Sponsors Bronze Sponsors

Admescope D2Asebio F3Avestin - Milmedtek A6Awex C2Belgium C2BIA Separations B4BioFinland D2Biomeva A1Biopeople E3BioTurku D2Biovian D2BioWin C2Business Region Göteborg D5Business Sweden E4Cancer Bio Santé C0Cancer Campus C0Copehagen Capacity E3Crown A5Danish Pavilion E3

Dansk Biotek E3DHMA F2DNE Pharma Holding G2FIMEA F2Finnish BioIndustries D2Finnish Pavilion D2Flanders Invest & Trade C2Genohm A7GU Holding D5Göteborg & Co D5Göteborg D5Helsinki Business Hub D2ICEX Invest in Spain F3Innomedica D2Innovation Akademiska D3Innovation Norway F1Inven2 F1Invest in Skane E2IRW A8

Karolinska Innovations C7Karolinska Science Park C6LIF D4Life Science Foresight Institute C5Life Science Nation 10Link Medical G1Medeon Science Park C6Medipan A3MPA F2NanoMed C5Nansen Neurosciences Network F1NextPharma D6NOMA F2Nordic Medical Product Agencies F2Norgenta – Life Science Nord C1

Norwegian BioindustryAssociation F1Norwegian Pavilion F1Oslo Cancer Cluster F1Pfizer E1Pharmatory D2Quintiles B1Recipharm D1Sahlgrenska Science Park C6Science Parks Sweden C6SGS B3Sinensis A4SP Process B6Spanish Pavilion F3Stockholm Business Region Development C4Stockholm Life D3Stockholm Science City D3Stockholm Uppsala D3

SwedenBIO D4Swedish BioPharma Industries D4SwissBiotech C3UKTI E5UppsalBIO D3Uppsala Innovation Center D3Uppsala University Innovation D3Valea B5VBU - Dechema A2Venture Valuation A9World Courier B2

Exhibitors

A1 A2

A9A8

B1 B6B5B4B3B2

C1 C6C5C4C3C2C7

D1

D6

D5D4D3D2

E1E5E4E3E2

F1 F2 F3

G1 G2

A5A3

A4 A7A6A10

C0

Produced with NLSDays Media Partner

Save the date 8-10 September 2015 for Nordic Life Science Days in Stockholm.